Breathe Well Live Well
|
Table 1. Main clinically relevant outcomes to assess asthma therapies
Medscape ACQ, Asthma Control Questionnaire; ACSS, Asthma Control Scoring System; ACT, asthma control test; BAL, Bronchoalveolar lavage; EBC, exhaled breath condensate; FEF, Forced expiratory flow; FENO, fractional exhaled nitric oxide; FEV1, forced expiratory … |
View full post on asthma – Google News
Condition: Healthy
Interventions: Drug: Fluticasone propionate; Device: Accuhaler
Sponsors: University Hospitals, Leicester; Genentech,Inc., South San Francisco, USA
Not yet recruiting – verified June 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Researchers to assess asthma risk in health care workers
Phys.Org Asthma prevalence is growing across the United States and certain occupational groups are more affected than others, including those in the health care field. In 2003, the researchers published the results of a survey that found an increased prevalence … |
View full post on asthma – Google News
|
UTHealth Researchers to Assess Asthma Risk in Healthcare Workers
Infection Control Today In 2003, the researchers published the results of a survey that found an increased prevalence of asthma among healthcare workers, especially nurses. After entering the healthcare field, 7.3 percent of nurses developed asthma while this figure was … Researchers to assess asthma risk in health care workers |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Ipratropium bromide; Drug: Placebo; Drug: Salbutamol
Sponsor: Boehringer Ingelheim
Terminated – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: PBF-680; Drug: Placebo
Sponsors: Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau; Palo Biofarma, S.L
Recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Budesonide Inhalation Aerosol (PT008) Dose 1; Drug: Budesonide Inhalation Aerosol (PT008) Dose 2; Drug: Budesonide Inhalation Aerosol (PT008) Dose 3; Drug: Budesonide Inhalation Aerosol (PT008) Dose 4; Drug: Placebo
Sponsor: Pearl Therapeutics, Inc.
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Severe IgE-mediated Asthma
Interventions: Drug: Omalizumab; Drug: Budesonide; Drug: Formoterol
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting – verified July 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: SOTB07 200mg; Drug: SOTB07 400mg; Drug: placebo
Sponsors: SK Chemicals Co.,Ltd.; SK Chemicals Co.,Ltd.
Recruiting – verified July 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: FF/VI 100/25 mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting – verified April 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days